Brief: Phibro Animal Health Corp Sees June 2020 Year EPS Of $0.84 - $0.90

Phibro Animal Health

28/08/2019 24:14

Aug 27 (Reuters) - Phibro Animal Health Corp  PAHC.O :
    * ORATION REPORTS FOURTH QUARTER AND FISCAL YEAR RESULTS,
PRESENTS
FINANCIAL GUIDANCE
    * SEES JUNE 2020 YEAR NET SALES OF $833 - $863 MILLION
    * SEES JUNE 2020 YEAR DILUTED EPS OF $0.84 - $0.90
    * SEES JUNE 2020 YEAR ADJUSTED DILUTED EPS OF $1.08 - $1.15
    * DURING THREE MONTHS ENDED JUNE 30, 2019, RECORDED PRE-TAX
CHARGES OF $6.3 MILLION FOR BUSINESS RESTRUCTURING ACTIVITIES
    * PHIBRO ANIMAL HEALTH - TO RECORD AN ADDITIONAL CHARGE FOR
EMPLOYEE SEPARATION COSTS OF AN ESTIMATED $1.0 MILLION AND
COMPLETE ACTIONS BY DECEMBER 31, 2019
    * SEES ANIMAL HEALTH SALES GROWTH FROM CURRENT AND NEW
PRODUCTS IN
FISCAL 2020
    * RECENT REGULATORY DEVELOPMENTS IN CHINA RESTRICTING USE OF
CERTAIN ANTIBIOTICS WILL AFFECT LOCAL DEMAND FOR MFAS
    * DO NOT EXPECT THERAPEUTIC CLAIMS FOR SWINE IN CHINA TO BE
APPROVED PRIOR TO 2021
    * PHIBRO ANIMAL HEALTH - DELAY IN THERAPEUTIC CLAIMS
APPROVAL DUE
TO RESTRICTIONS ON ANIMAL MOVEMENTS RESULTING FROM AFRICAN SWINE
FEVER
    * EXPECT FULL-YEAR DECLINE IN ADJUSTED EBITDA WILL OCCUR
ENTIRELY
IN FIRST HALF OF FISCAL YEAR
    * FY2020 EARNINGS PER SHARE VIEW $1.66, REVENUE VIEW $858.1
MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw2W0p43a 
Further company coverage:  PAHC.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))